KEITH JOHNSON: Open Payments
NPI 1902829583 · LEWISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 46 payments from 19 companies in 2025. Trend: 2023 $1,090 · 2024 $1,165 · 2025 $901
Food & beverage: $901
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $98 |
| Novo Nordisk Inc | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 5 | $87 |
| Lilly USA, LLC | 4 | $75 |
| Grifols USA, LLC | 3 | $69 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Astellas Pharma US Inc | 2 | $59 |
| IBSA Pharma Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $45 |
| ARGENX US, INC. | 2 | $43 |
Products named: MOUNJARO, Prolastin-C Liquid, GEMTESA, Veozah, Tirosint, Cologuard Collection Kit, VYVGART HYTRULO, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
